Carriers are equally important as drugs. They can substantially improve bioavailability of
cargos and safeguard healthy cells from toxic effects of certain therapeutics. Recently …

Nanogels are highly recognized as adaptable drug delivery systems that significantly
contribute to improving various therapies and diagnostic examinations for different human …

The blood–brain barrier represents a significant challenge for the treatment of high-grade
gliomas, and our understanding of drug transport across this critical biointerface remains …

Nanogels have high tunability and stability while being able to sense and respond to
external stimuli by showing changes in the gel volume, water content, colloidal stability …

Brain cancer remains the deadliest cancer. The blood–brain barrier (BBB) is impenetrable to
most drugs and is a complex 3D network of multiple cell types including endothelial cells …

Minimal therapeutic advances have been achieved over the past two decades for
glioblastoma (GBM), which remains an unmet clinical need. Here, hypothesis‐driven stimuli …

The blood–brain barrier (BBB) limits the access of substances to the central nervous system
(CNS) which hinders the treatment of pathologies affecting the brain and the spinal cord …

Chemotherapy and radiation remain as mainstays in the treatment of a variety of cancers
globally, yet some therapies exhibit limited specificity and result in harsh side effects in …

Deformability is one of the critical attributes of nanoparticle (NP) drug carriers, along with
size, shape, and surface properties. It affects various aspects of NP biotransport, ranging …

Drug nanocarriers (NCs) capable of crossing the vascular endothelium and deeply
penetrating into dense tissues of the CNS could potentially transform the management of …